VarmX
VarmX B.V. is manufacturing therapeutic proteins to instantaneously restore blood clotting in bleeding patients.
VarmX has raised €48M across 2 funding rounds from 2 investors, most recently a Series B round in May 2023. Based in Leiden, Netherlands; active in Healthtech. Data as of 28 Oct 2026.
Leiden, Netherlandswww.varmx.com ↗
Total raised
€48M
€47,500,000
Funding rounds
2
Investors
2
distinct backers
Active since
2021-10
latest 2023-05
Funding by year
EUR raised per yearVarmX — funding by year — interactive chart.
Data table
| VarmX — funding by year | |
|---|---|
| 2021 | €18M |
| 2023 | €30M |
Signals
High confidenceRaise-next likelihood10
base rate 48% for Series B
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood10
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 5y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-05-25 | Series B | €30M | European Innovation Council (EIC),Sound Bioventures | View deal → |
| 2021-10-21 | Other | €18M | European Innovation Council (EIC) | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData